A newly published article in the journal of New Microorganisms and New Infections (Epub ahead of print on August 20) shows that “no Torsade de Pointes or related deaths were found to have been reported as a result of HCQ and azithromycin use in the peer reviewed literature. To the contrary HCQ/azithromycin were uniformly found to substantially reduce cardiac mortality and also to decrease thrombosis, arrhythmia and cholesterol in treated patients in recent peer reviewed studies and meeting presentations.” This negates FDA and CDC’s warning of “fatal cardiac toxicity from Torsade de Pointes (TDP) arrhythmia from HCQ use”. This study shows that the restriction on the use of HCQ to treat patients infected with CCP virus lacks scientific basis.
Read Chinese translation (click to download pdf)
Translator：【 一花一世界 】【Naomi (文花开) 】【 奔腾的长江 】Proofreader&Editor：【Michelle】
Presented by the VOG Rose Garden Team